logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
F

Funda Meric‐Bernstam

The University of Texas MD Anderson Cancer Center

146H-index
2.6KPaper Count
10.6WCitation Count
Published Papers 595
Publication Date
logo
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial
errNature Communications
IF15.7
err2026-08-22
err0
errOAAI
errVicente Valero; Paula R. Pohlmann; Jason Mouabbi; Xuelin Huang; Wei Qiao; Heather Alonzo; Rashmi K. Murthy; Gaiane M. Rauch; Taiwo Adesoye; Cristina Checka; Fraser W. Symmans; Dmitrii Grachev; Flora Alajajyan; Adaeze Nwosu-Iheme; Amy Hassan; Miral Patel; Sharon H. Giordano; Kelly Hunt; Debasish Tripathy; Funda Meric-Bernstam
errShare
errSave
Antibody-drug conjugates in breast cancer: Progress and future directions
errCell Reports Medicine
IF10.6
err2026-04-07
err0
errOAAI
errAlexandra Bili Newman; Senthil Damodaran; Funda Meric-Bernstam
errShare
errSave
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology
errSignal Transduction and Targeted Therapy
IF52.7
err2026-02-24
err0
errOAAI
errStephanie T. Schmidt; Mehmet A. Baysal; Siqing Fu; David S. Hong; Sarina A. Piha-Paul; Aung Naing; Jordi Rodon Ahnert; Timothy A. Yap; Ecaterina Elena Dumbrava; Jennifer Beck; Funda Meric-Bernstam; Apostolia Maria Tsimberidou
errShare
errSave
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction
errNature Communications
IF15.7
err2026-01-22
err0
errOAAI
errLinjie Luo; Yan Wang; Tuyen Bui; Xiaoting Jiang; Mei-Kuang Chen; Xiayu Rao; Sepideh Mohammadhosseinpour; Mi Li; Serena Kim; Rachel Y. Kim; Saba Kamaliasl; Carmen W. Ulizio; Spyros Tsavachidis; Juliana Navarro-Yepes; Nicole M. Kettner; Hannah Wingate; Funda Meric-Bernstam; Kelly K. Hunt; Jing Wang; Kerrie Faia; Khandan Keyomarsi
errShare
errSave
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
errNature Reviews Clinical Oncology
IF82.2
err2026-01-05
err0
PREAI
errAmber Johnson; Yifei Shen; Xiaofeng Zheng; Fei Su; Jia Zeng; Burak Uzunparmak; Eun-Kyoung Breuer; Vijaykumar Holla; Michael Kahle; Sun-Hee Kim; Thuy Vu; Kenna R. Mills Shaw; Ecaterina Ileana Dumbrava; Timothy A. Yap; Jordi Rodon; Mark Routbort; Keyur Patel; Shashikant Kulkarni; Donna Hansel; Julian Bryan; Anil Korkut; Ken Chen; Funda Meric-Bernstam
errShare
errSave
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling
errnpj Breast Cancer
IF7.6
err2025-12-20
err0
errOAAI
errGeorge W. Sledge; Joanne Xiu; Reshma L. Mahtani; Ana C. Sandoval Leon; Funda Meric-Bernstam; Jennifer R. Ribeiro; Ninad N. Kulkarni; Dileep R. Rampa; Jangsoon Lee; Naoto T. Ueno; Matthew J. Oberley; Milan Radovich; David B. Spetzler
errShare
errSave
Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study
errBreast Cancer Research
IF5.6
err2025-11-05
err0
errOAAI
errMaria Azhar; Felipe Soto; Amber Su; Norma Alicia Vazquez Gonzalez; Kevin Bernal Medina; Alejandro Lizarraga Madrigal; Cesar Chavez Duran; Carlos Ignacio Rodriguez Reyna; Colin Chan; Girish S. Shroff; Roland L. Bassett; Sarah Pasyar; David Zhang; Vickie R. Shannon; Mehmet Altan; Melissa P. Mitchell; Funda Meric-Bernstam; Jason Mouabbi; Rashmi K. Murthy; Saadia A. Faiz; Lara Bashoura; Bora Lim; Ajay Sheshadri
errShare
errSave
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors
errFuture Oncology
IF2.6
err2025-10-14
err0
errOAAI
errThomas Powles; Aarti Bhatia; Barbara Burtness; Takahiro Kogawa; Tomohiro Nishina; Izuma Nakayama; Christos Fountzilas; Dani R. Castillo; Meredith McKean; Funda Meric-Bernstam; Nicoletta Colombo; James W. Smithy; Jérome Fayette; Sunandana Chandra; David W. Sternberg; Fan Jin; Kendall Sullivan; Sue Yueh; Graham Clinthorne; Ariel E. Aguilo; Ragini Kudchadkar; Hidetoshi Hayashi
errShare
errSave
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy
errRSC Med. Chem.
IF3.6
err2025-08-22
err0
errOAAI
errUjjwol Khatri; Neetu Dayal; Kofi B. Owusu; Mandeep Kaur Hunjan; Shriya Pandey; Haley Anne Harper; Carli McMahan; Bennett D. Elzey; Tao Shen; Xueqing Hu; Kurt W. Evans; Ahmed El-Sheikh; Seong jun Jo; Frederick W. Holtsberg; M. Javad Aman; Funda Meric-Bernstam; Sukyung Woo; Herman O. Sintim; Jie Wu
errShare
errSave
Emerging molecular Therapeutic targets in breast Cancer: Pathologic identification and clinical implications
errHuman Pathology
IF2.6
err2025-08-05
err0
PREAI
errAysegul A. Sahin; Hui Chen; Huang Xiao; Damodaran Senthil; Funda Meric-Bernstam
errShare
errSave
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
errnpj Precision Oncology
IF8
err2025-07-25
err0
errOAAI
errNicole M. Kettner; Tuyen N. Bui; Juliana Navarro-Yepes; Sanaz Ghotbaldini; Bethanie Quintela; Catherine K. Luo; Nghi Lam; Xiayu Rao; Akshara Singareeka Raghavendra; Yan Wang; Nancy Azizian; T. Kris Eckols; Moses Makokha Kasembeli; Kurt Evans; Min Yi; Hannah Wingate; Jing Wang; Aysegul A. Sahin; Funda Meric-Bernstam; Kelly K. Hunt; Senthil Damodaran; David J. Tweardy; Debu Tripathy; Khandan Keyomarsi
errShare
errSave
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
errMOLECULAR ONCOLOGY
IF4.5
err2025-05-28
err0
errOAAI
errCharles Swanton; Russell W. Madison; Candice Francheska B. Tambaoan; Funda Meric-Bernstam; Christopher J. Sweeney; Razelle Kurzrock; Howard A. Burris III; David R. Spigel; Hanna Tukachinsky; Jason Hughes; Julia Malato; Bongin Yoo; Tania Szado; Cheryl Schwab; Lincoln W. Pasquina; Amaya Gasco; Katja Schulze; Claire F. Friedman
errShare
errSave
Predicting pathologic ≥N2 disease in women with breast cancer
errNPJ BREAST CANCER
IF7.6
err2025-05-22
err0
errOAAI
errWanis, Kerollos Nashat; Dong, Wenli; Shen, Yu; Meric-Bernstam, Funda; Adesoye, Taiwo; Kuerer, Henry M.; Caudle, Abigail S.; Tamirisa, Nina; Desnyder, Sarah M.; Sun, Susie X.; Bedrosian, Isabelle; Singh, Puneet; Cox, Solange E.; Hunt, Kelly K.; Hwang, Rosa F.
errShare
errSave
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
errShare
errSave
Optimizing TROP2 Immunohistochemistry Scoring by Automated Quantitative Image Analysis for Generating Clinical Trial-Driven IHC Scores
errLABORATORY INVESTIGATION
IF4.2
err2025-03-01
err0
PREAI
errGuerrouahen, Bella; San Lucas, Francis; Wang, Wei-Lien (Billy); Roy-Chowdhuri, Sinchita; Suchko, Michael; Sun, Baohua; Shah, Khushali Patel; Reddy, Neelima; Mantha, Geeta; Meric-Bernstam, Funda; Chen, Hui
errShare
errSave
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (vol 40, pg 290, 2022)
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2025-02-20
err0
errOAAI
errThein, Kyaw Z.; Karp, Daniel D.; Tsimberidou, Apostolia; Gong, Jing; Sulovic, Selma; Shah, Jatin; Milton, Denai R.; Hong, David S.; Janku, Filip; Mcquinn, Lacey; Stephen, Bettzy A.; Colen, Rivka; Carter, Brett W.; Yap, Timothy A.; Piha-Paul, Sarina A.; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer
errgynecologic oncology
IF4.1
err2025-02-01
err1
PREAI
errAhmed, Jibran; Stephen, Bettzy; Khawaja, Muhammad R.; Yang, Yali; Salih, Israa; Barrientos-Toro, Elizve; Raso, Maria Gabriela; Karp, Daniel D.; Piha-Pa, Sarina A.; Sood, Anil K.; Ng, Chaan S.; Johnson, Amber; Soliman, Pamela T.; Meric-Bernstam, Funda; Luc, Karen H.; Naing, Aung
errShare
errSave
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers
errCANCER
IF5.1
err2025-01-23
err0
PREAI
errAhmed, Jibran; Janku, Filip; Karp, Daniel D.; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Yap, Timothy Anthony; Stephen, Bettzy; Yang, Yali; Gurses, Serdar; Liu, Qian; Song, Juhee; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
errNPJ PRECISION ONCOLOGY
IF8
err2025-01-04
err0
errOAAI
errKim, Daehwan; Chung, Heekyung; Liu, Wen; Jeong, Kangjin; Ozmen, Tugba Y.; Ozmen, Furkan; Rames, Matthew J.; Kim, Sangyub; Guo, Xiao; Jameson, Nathan; de Jong, Petrus R.; Yea, Steven; Harford, Laurie; Li, Jiali; Mathews, Cara A.; Doroshow, Deborah B.; Charles, Vincent J.; Kim, Doris; Fischer, Kimberlee; Samatar, Ahmed A.; Jubb, Adrian; Bunker, Kevin D.; Blackwell, Kimberly; Simpkins, Fiona; Meric-Bernstam, Funda; Mills, Gordon B.; Harismendy, Olivier; Ma, Jianhui; Lackner, Mark R.
errShare
errSave
An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errLee, J-Y.; Makker, V.; Oaknin, A.; Oh, D-y.; Anoka, C.; Jung, L.; Simoes, J.; Puvvada, S. D.; Meric-Bernstam, F.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Gordon B. Mills
H-index: 231 · Papers: 3.5K
M
Marc Ladanyi
H-index: 204 · Papers: 2.5K
G
Gabriel N. Hortobágyi
H-index: 187 · Papers: 1.9K
J
John N. Weinstein
H-index: 163 · Papers: 987
M
Mien‐Chie Hung
H-index: 163 · Papers: 1.5K
View more